^†with Suda as the first affiliation; ^#co-first authors; ^*corresponding author

 

1.   ^†Bao M^#, Cao Z^#, Yu D, Fu S, Zhang G, Yang P, Pan Y, Yang B, Han H, Zhou Q*. Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity. Toxicol Lett 2012;215:174-80.

2.  ^†Bu Z^#, Pan Y^#, Shang B, Cao Z, Zhou Q*, Ruan C. SZ-117, a monoclonal antibody against matrix metalloproteinase-2 inhibits tumor cell-mediated angiogenesis. Hybridoma 2012;31:63-7.

3.   ^†Bu Z^#, Liu R^#, Shang B, Cao Z, Pan Y, Zhou Q*, Ruan C. A monoclonal antibody SZ-117 that recognizes filamin A derived from tumor cells. Hybridoma 2012;31:214-8.

4.   Cui Y^#, Wang W^#, Dong N^#, Lou J^#, Srinivasan D, Cheng W, Huang X, Liu M, Fang C, Peng J, Chen S, Wu S, Liu Z, Dong L, Zhou Y, Wu Q*. Role of corin in trophoblast invasion and uterine spiral artery remodeling in pregnancy. Nature 2012;484:246-50.

5.   Dai J^#, Agelan A^#, Yang A^#, Zuluaga V, Sexton D, Colman RW, Wu Y*. Role of plasma kallikrein-kinin system activation in synovial recruitment of endothelial progenitor cells in experimental arthritis. Arthritis Rheum 2012;64:3574-82.

6.   ^†Dong J^#, Zhao X^#, Shi S^#, Ma Z, Liu M, Wu Q, Ruan C, Dong N*. Identification and functional analysis of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease. PLoS One 2012;7:e33263.

7.   ^†Dong N*, Chen S, Wang W, Zhou Y, Wu Q*. Corin in clinical laboratory diagnostics. Clin Chim Acta 2012;413:378-83. *co-corresponding authors

8.   ^†Feng Y^#, Zhang S^#, Tu J, Cao Z, Pan Y, Shang B, Liu R, Bao M, Guo P, Zhou Q*. A novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt's lymphoma Namalwa cells. Leuk Lymphoma 2012;53:2456-64.

9.   Godard MP*, Whitman SA, Song YH, Delafontaine P. Skeletal muscle molecular alterations precede whole muscle dysfunction in NYHA class II heart failure patients. Clin Interv Aging 2012;7:489-97.

10.  Guo D^#, Zhang X^#, Huang Z, Zhou X, Zhu L, Zhao Y, Gu N*. Comparison of cellular responses across multiple passage numbers in Ba/F3-BCR-ABL cells induced by silver nanoparticles. Sci China Life Sci 2012;55:898-905.

11.  ^†Hu B, Bao G, Zhang Y, Lin D, Wu Y, Wu D*, Liu H*. Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation. J Immunol 2012;189:1661-70. *co-corresponding authors

12.  ^†Li T, Yang J, Zhou Q, He Y*.Molecular regulation of lymphangiogenesis in development and tumor microenvironment. Cancer Microenviron 2012;5:249-60.

13.  ^†Ling C*, Chen G, Chen G, Zhang Z, Cao B, Han K, Yin J, Chu A, Zhao Y, Mao X. A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo. Int J Cancer 2012;131:2411-9.

14.  ^†Liu R^#, Cao Z^#, Tu J, Pan Y, Shang B, Zhang G, Bao M, Zhang S, Yang P, Zhou Q*. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry. Pigment Cell Melanoma Res 2012;25:630-8.

15.  Mao X, Cao B. The Ubiquitin-Proteasomal System and Blood Cancer Therapy. In: Hematology-Science and Practice. (Charles H. Lawrie, Ed), pp 497-516, InTech, 2012.

16.  Sajish M, Zhou Q, Kishi S, Valdez D, Kapoor M, Guo M, Kim S, Yang X, Schimmel P. Nuclear TrpRS links IFN-γ signaling to p53 activation. Nat Chem Biol 2012; 8:547-54.

17.  ^†Shang B, Zhang G, Pan Y, Zhou Q*. Deciphering the key features of malignant tumor microenvironment for anti-cancer therapy. Cancer Microenviron 2012;5:211-23.

18.  ^†Shang B, Cao Z, Zhou Q*. Normalization of tumor blood vessels for anti-cancer therapy. Front Med 2012;6:67-78.

19.  Wang W, Cui Y, Shen J, Jiang J, Chen S, Peng J, Wu Q*. Salt-sensitive hypertension and cardiac hypertrophy in transgenic mice expressing a corin variant identified in blacks. Hypertension 2012;60:1352-8.

20.  Wang W^#, Shen J^#, Cui Y, Jiang J, Chen S, Peng J, Wu Q*. Impaired sodium excretion and salt-sensitive hypertension in corin-deficient mice. Kidney Int 2012;82:26-33.

21.  ^†Wu Y^#, Ahmad SS^#, Zhou J, Wang L, Cully MP, Essex DW*. The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis. Blood 2012;119:1737-46.

22.  ^†Zhao L, Liu H*. Newcastle disease virus: a promising agent for tumour immunotherapy. Clin Exp Pharmacol Physiol 2012;39:725-30.

23.  ^†Zhang G, Shang B, Yang P, Cao Z, Pan Y, Zhou Q*. Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy. Stem Cells Dev 2012;21:955-64.

24.  ^†Zhang L, Jiang G*, Yao F, He Y, Liang G, Zhang Y, Hu B, Wu Y, Li Y, Liu H*. Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma. PLoS One 2012;7:e37865. *co-corresponding authors

25.  ^†Zhang X^#, Jing Y^#, Qin Y, Hunsucker S, Meng H, Sui J, Jiang Y, Gao L, An G, Yang N, Orlowski RZ, Yang L*. The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration. Int J Biochem Cell Biol 2012;44:1166-73.

26.  ^†Zhang Y, Cheng Y, Ren X, Hori T, Huber-Keener KJ, Zhang L, Yap KL, Liu D, Shantz L, Qin ZH, Zhang S, Wang J, Wang HG, Shih IeM, Yang JM*. Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis. Cancer Res 2012;72:4262-75.

27.  ^†Zhu J, Li Y, Yu H, Zhang L, Mao X*, Hou T*. Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses. Comb Chem High Throughput Screen 2012;15:439-50. *co-corresponding authors